BR9915379A - Forma de dosagem e processo para a preparação de uma forma de dosagem - Google Patents
Forma de dosagem e processo para a preparação de uma forma de dosagemInfo
- Publication number
- BR9915379A BR9915379A BR9915379-3A BR9915379A BR9915379A BR 9915379 A BR9915379 A BR 9915379A BR 9915379 A BR9915379 A BR 9915379A BR 9915379 A BR9915379 A BR 9915379A
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- preparing
- amifostine
- amorphous
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
"FORMA DE DOSAGEM E PROCESSO PARA A PREPARAçãO DE UMA FORMA DE DOSAGEM". A presente invenção refere-se às formas de dosagem estáveis, estéreis, adequadas para reconstituição e administração parenteral a um paciente, a citada forma de dosagem compreendendo um di-hidrogeno-fósforo-tioato de amino-alquila amorfo, e em particular amifostina. A invenção refere-se adicionalmente a um processo de preparação de uma tal forma de dosagem, que tipicamente exibe estabilidade térmica aumentada em comparação com a existente amifostina amorfa seca a vácuo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/192,933 US6407278B2 (en) | 1998-11-16 | 1998-11-16 | Stable amorphous amifostine compositions and methods for the preparation and use of the same |
PCT/US1999/027050 WO2000029025A1 (en) | 1998-11-16 | 1999-11-15 | Stable amorphous amifostine compositions and methods for the preparation and use of same |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9915379A true BR9915379A (pt) | 2002-01-15 |
Family
ID=22711626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9915379-3A BR9915379A (pt) | 1998-11-16 | 1999-11-15 | Forma de dosagem e processo para a preparação de uma forma de dosagem |
Country Status (16)
Country | Link |
---|---|
US (1) | US6407278B2 (pt) |
EP (1) | EP1131103A1 (pt) |
JP (1) | JP4703854B2 (pt) |
KR (1) | KR20010101015A (pt) |
CN (1) | CN1195549C (pt) |
AU (1) | AU1725500A (pt) |
BR (1) | BR9915379A (pt) |
CA (1) | CA2350815C (pt) |
CZ (1) | CZ20011722A3 (pt) |
HK (1) | HK1041639B (pt) |
HU (1) | HUP0104372A2 (pt) |
ID (1) | ID30238A (pt) |
MX (1) | MXPA01004867A (pt) |
PL (1) | PL347691A1 (pt) |
SK (1) | SK6672001A3 (pt) |
WO (1) | WO2000029025A1 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994409A (en) * | 1997-12-09 | 1999-11-30 | U.S. Bioscience, Inc. | Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds |
US6384259B1 (en) * | 1998-11-16 | 2002-05-07 | Medimmune Oncology, Inc. | Stable amorphous amifostine compositions and dosage form |
DE10043170C2 (de) * | 2000-09-01 | 2002-10-24 | Klinge Co Chem Pharm Fab | Amifostin-Monohydrat und Verfahren zu seiner Herstellung |
ATE326985T1 (de) * | 2002-02-01 | 2006-06-15 | Shimoda Biotech Pty Ltd | Lyophilisierte pharmazeutische zusammensetzung von propofol |
US7629333B2 (en) * | 2002-03-29 | 2009-12-08 | Medimmune, Llc | Stable amorphous amifostine compositions and methods for the preparation and use of same |
US20030215394A1 (en) * | 2002-05-17 | 2003-11-20 | Short Robert E. | Microparticles having a matrix interior useful for ultrasound triggered delivery of drugs into the bloodstream |
SI21302A (sl) * | 2002-10-11 | 2004-04-30 | LEK farmacevtska dru�ba d.d. | Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino |
US20050049209A1 (en) * | 2003-08-06 | 2005-03-03 | Chen Andrew Xian | Pharmaceutical compositions for delivering macrolides |
DK1683524T3 (da) * | 2003-11-14 | 2011-03-14 | Ajinomoto Kk | Dispergering på fast form eller medicinsk præparat på fast form af phenyalaninderivat |
JP4526838B2 (ja) * | 2004-03-04 | 2010-08-18 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 配合適性試験用試料の調製方法及びそれに用いるキット |
WO2006044738A2 (en) * | 2004-10-18 | 2006-04-27 | Maroon Biotech Corporation | Methods and compositions for treatment of free radical injury |
US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
WO2007108463A1 (ja) * | 2006-03-23 | 2007-09-27 | Shionogi & Co., Ltd. | 溶解性が改善された固形製剤 |
WO2008060441A2 (en) * | 2006-11-09 | 2008-05-22 | Scidose Llc | Stable amifostine liquid concentrate |
WO2008119032A1 (en) | 2007-03-27 | 2008-10-02 | Perscitus Biosciences, Llc | Compositions and methods for protecting cells from toxic exposures |
JPWO2009038112A1 (ja) | 2007-09-21 | 2011-01-06 | 塩野義製薬株式会社 | Npyy5受容体拮抗剤を含有する固形製剤 |
CN101347412B (zh) * | 2008-09-02 | 2011-07-27 | 大连美罗药业股份有限公司 | 三水合氨磷汀结晶冻干制剂及其制备方法 |
JP5563528B2 (ja) * | 2010-06-29 | 2014-07-30 | 高田製薬株式会社 | ニコチン酸アミドを含有するゲムシタビン凍結乾燥製剤 |
CN102286019B (zh) * | 2011-07-11 | 2014-02-05 | 大连美罗大药厂 | 二水合3-氨基丙基胺乙基硫代磷酸的制备方法 |
CN104744478B (zh) * | 2015-03-20 | 2016-08-24 | 中国人民解放军第二军医大学 | 一种防治辐射损伤的化合物、单晶及其制备方法和应用 |
EP3330251A1 (en) * | 2016-11-30 | 2018-06-06 | Clevexel Pharma | Process for the preparation of freeze-dried 2-[(3-aminopropyl)amino]ethanethiol |
CN113164420A (zh) * | 2018-10-01 | 2021-07-23 | 温特穆特生物医学公司 | 治疗组合物 |
CN110755373B (zh) * | 2019-11-18 | 2020-09-08 | 扬子江药业集团广州海瑞药业有限公司 | 一种盐酸法舒地尔注射液药物组合物及制备方法 |
CN116283682B (zh) * | 2023-02-21 | 2024-08-02 | 梯尔希(南京)药物研发有限公司 | 一种同位素标记的氨磷汀代谢物的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3892824A (en) | 1968-12-16 | 1975-07-01 | Southern Res Inst | S-{107 -({107 -aminoalkylamino)alkyl dihydrogen phosphorothioates |
JPS6041676B2 (ja) | 1977-09-21 | 1985-09-18 | 山之内製薬株式会社 | S−2−(3−アミノプロピルアミノ)エチルジハイドロジエンホスホロチオエ−ト1水和結晶の新規製法 |
US4424216A (en) | 1979-07-31 | 1984-01-03 | The Rockefeller University | Method for the reduction of mucin viscosity |
SG47101A1 (en) | 1992-07-31 | 1998-03-20 | Us Bioscience | Crystalline amifostine compositions and methods for the preparation and use of same |
US5424471A (en) * | 1992-07-31 | 1995-06-13 | U.S. Bioscience, Inc. | Crystalline amifostine compositions and methods of the preparation and use of same |
US5665760A (en) * | 1995-09-18 | 1997-09-09 | Sanofi Winthrop, Inc. | Lyophilized thioxanthenone antitumor agents |
JP2000509018A (ja) * | 1996-03-26 | 2000-07-18 | イーライ・リリー・アンド・カンパニー | 肥満タンパク質製剤 |
US6051563A (en) | 1997-02-12 | 2000-04-18 | U.S. Bioscience, Inc. | Methods for the administration of amifostine and related compounds |
WO1998037869A1 (fr) * | 1997-02-27 | 1998-09-03 | Nippon Shinyaku Co., Ltd. | Emulsion grasse s'administrant par voie orale |
-
1998
- 1998-11-16 US US09/192,933 patent/US6407278B2/en not_active Expired - Lifetime
-
1999
- 1999-11-15 EP EP99960360A patent/EP1131103A1/en not_active Withdrawn
- 1999-11-15 MX MXPA01004867A patent/MXPA01004867A/es active IP Right Grant
- 1999-11-15 PL PL99347691A patent/PL347691A1/xx not_active Application Discontinuation
- 1999-11-15 AU AU17255/00A patent/AU1725500A/en not_active Abandoned
- 1999-11-15 WO PCT/US1999/027050 patent/WO2000029025A1/en not_active Application Discontinuation
- 1999-11-15 CZ CZ20011722A patent/CZ20011722A3/cs unknown
- 1999-11-15 JP JP2000582071A patent/JP4703854B2/ja not_active Expired - Fee Related
- 1999-11-15 BR BR9915379-3A patent/BR9915379A/pt not_active Application Discontinuation
- 1999-11-15 CN CNB998156299A patent/CN1195549C/zh not_active Expired - Fee Related
- 1999-11-15 KR KR1020017006142A patent/KR20010101015A/ko not_active Application Discontinuation
- 1999-11-15 HU HU0104372A patent/HUP0104372A2/hu unknown
- 1999-11-15 ID IDW00200101302A patent/ID30238A/id unknown
- 1999-11-15 CA CA002350815A patent/CA2350815C/en not_active Expired - Fee Related
- 1999-11-15 SK SK667-2001A patent/SK6672001A3/sk unknown
-
2002
- 2002-04-17 HK HK02102910.1A patent/HK1041639B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2350815A1 (en) | 2000-05-25 |
SK6672001A3 (en) | 2001-11-06 |
CN1195549C (zh) | 2005-04-06 |
WO2000029025A1 (en) | 2000-05-25 |
PL347691A1 (en) | 2002-04-22 |
ID30238A (id) | 2001-11-15 |
CN1333694A (zh) | 2002-01-30 |
JP2002529519A (ja) | 2002-09-10 |
CA2350815C (en) | 2008-10-07 |
EP1131103A1 (en) | 2001-09-12 |
US6407278B2 (en) | 2002-06-18 |
US20020010357A1 (en) | 2002-01-24 |
HK1041639A1 (en) | 2002-07-19 |
HUP0104372A2 (hu) | 2002-04-29 |
HK1041639B (zh) | 2005-09-30 |
AU1725500A (en) | 2000-06-05 |
CZ20011722A3 (cs) | 2001-10-17 |
MXPA01004867A (es) | 2003-07-21 |
JP4703854B2 (ja) | 2011-06-15 |
KR20010101015A (ko) | 2001-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9915379A (pt) | Forma de dosagem e processo para a preparação de uma forma de dosagem | |
BR0210594A (pt) | (beta)-d ou (beta)-l-3-halonucleosìdeo | |
CO5050303A1 (es) | Composicion farmaceutica para tratar infecciones virales y metodos para su preparacion su aplicacion | |
AR013742A1 (es) | Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida | |
CO5570109A1 (es) | Compuestos de dihidropirimidina heterociclicos | |
BRPI0010891A (pt) | geração de microespuma terapêutica. | |
BR0017030A (pt) | Derivados de tiazolilamida | |
PT1416935E (pt) | Derivados de 4-amino-6-fenil-pirrolo[2,3-d]pirimidina | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
DE69905712T2 (de) | Verwendung von indigoähnlichen bisindolen zur herstellung eines arzneimittels zur hemmung cyclin abhängiger kinasen | |
BR0209845A (pt) | Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas | |
BR0116332A (pt) | Processo para o aumento da estabilidade | |
ES2067854T3 (es) | Polisulfato de derivado de ciclodextrina y procedimiento para preparar el mismo. | |
ES2100841T3 (es) | 3,9-difosfaespiroundecanos y procedimiento para preparar 3,9-difosfaespiroundecanos. | |
BR0309691A (pt) | Formulação de ibandronato em alta dose | |
CA2319217A1 (en) | Pharmaceutical compositions | |
CA2364251A1 (en) | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs | |
TR200001288T2 (tr) | Östrojen yoksunluğu sendromunun tedavisinde faydalı 2-arilbenzo (b) tiyofenler. | |
DK1007055T3 (da) | Anvendelse af amifostin | |
BR9906391A (pt) | "processo para a produção de n-metil pirrolidona". | |
DK0541594T3 (da) | Cyklopentan-derivater, fremgangsmåde til fremstilling deraf samt farmaceutisk anvendelse af derivaterne | |
CO5150178A1 (es) | Bromohidrato de eletriptan monohidrato y procedimiento para su preparacion | |
AR027016A1 (es) | Proceso para la estabilizacion de vino | |
CO5170480A1 (es) | Proceso para preparar (1r, 2s, 4r)-(-)-2-((2´-(n,n- dimetilamino)-etoxi))-2-(fenil)-1,7,7-tri-(metil)- biciclo (2.2.1) heptano y sales de adicion de acido farmaceuticamente aceptables del mismo | |
GT199900062A (es) | Preparados efervescentes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TC | Change of name | ||
TE | Change of address | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O, 13, 24 E 25 DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |